{"id":"W2566019957","doi":"10.1182/blood.v104.11.4225.4225","title":"CERA (Continuous Erythropoietin Receptor Activator): Dose-Response Trial of Subcutaneous (SC) Administration Once Every 3 Weeks (Q3W) to Patients with Aggressive Non-Hodgkin’s Lymphoma and Anemia Receiving Chemotherapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Anemia; Internal medicine; Gastroenterology; Chemotherapy; Chemotherapy regimen; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004336004,0.0003616977,0.0006382627,0.0001884495,0.0001343221,0.00005462638,0.0001954801,0.000258314,0.00009000035],"category_scores_gemma":[0.0006817691,0.0003063286,0.00009628409,0.0004029591,0.0002238738,0.0001614458,0.00006977024,0.0002121007,0.00002144192],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002930088,"about_ca_system_score_gemma":0.007190821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006228671,"about_ca_topic_score_gemma":0.00008898131,"domain_scores_codex":[0.9971529,0.0001517928,0.0005581867,0.0006656065,0.0009112003,0.0005603022],"domain_scores_gemma":[0.9978362,0.0003978273,0.0004332221,0.0006200221,0.0003313549,0.000381342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8749608,0.008104865,0.005521267,0.0004727749,0.000567347,0.001621032,0.005618185,0.0000234109,0.06446647,0.000007397286,0.0004110506,0.03822545],"study_design_scores_gemma":[0.6884233,0.02715342,0.04342738,0.001950305,0.0002736822,0.001224842,0.0003846684,0.00001878527,0.2358617,0.00001752679,0.000584278,0.0006800559],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996709,0.00010247,0.00003075248,0.0005342931,0.0001604221,0.002170317,0.00003439939,0.00006542145,0.0001929362],"genre_scores_gemma":[0.9967719,0.0001194956,0.002177421,0.0001334811,0.0002682949,0.00007532487,0.00003348418,0.00008830375,0.0003322854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1865374,"threshold_uncertainty_score":0.9999389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007099199901736731,"score_gpt":0.2591046772744383,"score_spread":0.2520054773727016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}